Literature DB >> 1433404

Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.

L B Hinshaw1, T E Emerson, F B Taylor, A C Chang, M Duerr, G T Peer, D J Flournoy, G L White, S D Kosanke, C K Murray.   

Abstract

A successful experimental treatment for gram-positive sepsis to our knowledge has not been achieved. The objectives of this study were to develop a nonhuman primate model of lethal gram-positive sepsis employing the micro-organism Staphylococcus aureus and to determine the efficacy of treatment using monoclonal antibody (MAb) to tumor necrosis factor alpha (TNF). The antibody was administered intravenously, 15 mg/kg, 30 minutes after the beginning of a 2-hour infusion of S. aureus, 4 x 10(10) colony forming units/kilogram. The baboons infused with S. aureus demonstrated the release of the cytokines TNF and interleukin-6 (IL-6), but endotoxin was not observed in the plasma at any time. Treatment with antibody to TNF abolished the rise in serum TNF levels and reduced the increased levels of IL-6. Treatment with MAb to TNF prevented multiple organ failure and achieved permanent (> 7 day) survival of all baboons.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433404

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  19 in total

1.  Dephosphorylation of endotoxin by alkaline phosphatase in vivo.

Authors:  K Poelstra; W W Bakker; P A Klok; J A Kamps; M J Hardonk; D K Meijer
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Involvement of Gr-1 dull+ cells in the production of TNF-α and IL-17 and exacerbated systemic inflammatory response caused by lipopolysaccharide.

Authors:  Daiki Tanno; Yukiko Akahori; Masahiko Toyama; Ko Sato; Daisuke Kudo; Yuzuru Abe; Tomomitsu Miyasaka; Hideki Yamamoto; Keiko Ishii; Emi Kanno; Ryoko Maruyama; Shigeki Kushimoto; Yoichiro Iwakura; Kazuyoshi Kawakami
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

3.  Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death.

Authors:  Robert Silasi; Ravi Shankar Keshari; Cristina Lupu; Walter Janse Van Rensburg; Hala Chaaban; Girija Regmi; Aleksandr Shamanaev; Joseph J Shatzel; Cristina Puy; Christina U Lorentz; Erik I Tucker; David Gailani; András Gruber; Owen J T McCarty; Florea Lupu
Journal:  Blood Adv       Date:  2019-02-26

Review 4.  Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?

Authors:  Georgia R Sampedro; Juliane Bubeck Wardenburg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.

Authors:  J E Souness; M Griffin; C Maslen; K Ebsworth; L C Scott; K Pollock; M N Palfreyman; J A Karlsson
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  Induction of nitric oxide production by polyosides from the cell walls of Streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta.

Authors:  V Martin; A L Kleschyov; J P Klein; A Beretz
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

Review 7.  Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.

Authors:  P Minneci; K Deans; C Natanson; P Q Eichacker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-28       Impact factor: 3.267

8.  Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection.

Authors:  L Yao; J W Berman; S M Factor; F D Lowy
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

9.  Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice.

Authors:  A Nakane; M Okamoto; M Asano; M Kohanawa; T Minagawa
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsis.

Authors:  James W T Yates; Shampa Das; Guy Mainwaring; John Kemp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-09-23       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.